PERHAPS A GIFT VOUCHER FOR MUM?: MOTHER'S DAY

Close Notification

Your cart does not contain any items

Hepatitis C Direct Acting Antivirals

The New Standard of Care, An Issue of Clinics in Liver Disease

Fred Poordad (University of Texas Health Science Center, San Antonio, Texas)

$163.95

Hardback

Not in-store but you can order this
How long will it take?

QTY:

English
W B Saunders Co Ltd
23 September 2011
Hepatitis C Virus is a quickly evolving area within hepatology owing to new medical therapies. This issue, guest edited by Dr. Fred Poordad, includes the most current clinical information and treatment therapies. Expert authors have written review articles devoted to the following medical therapies: Boceprevir, Telaprevir, Protease Inhibitors in Development, NS5B Nucleoside and Non-Nucleoside Inhibitors. Review articles also address important patients like naïve- and non-responders and relapsers, the HIV co-infected patient, and the Genotype 1 and non-Genotype 1 patient.

By:  
Imprint:   W B Saunders Co Ltd
Country of Publication:   United Kingdom
Volume:   15-3
Dimensions:   Height: 239mm,  Width: 163mm,  Spine: 18mm
Weight:   460g
ISBN:   9781455711079
ISBN 10:   1455711071
Series:   The Clinics: Internal Medicine
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Hardback
Publisher's Status:   Active

See Also